SUMMIT, NJ — May 3. In honor of May, Lupus Awareness Month, former Super Bowl Champion and Barstool Sports radio personality Willie Colon, hosted the annual Willie Colon Golf Outing for the Lupus Research Alliance (LRA). Dedicated to advancing lupus research, Mr. Colon is a member of the Lupus Research Alliance Board of Directors. In […] READ MORE
May 1, 2021 Dear Friends, 2020 will forever be remembered as the year of COVID-19 with much sacrifice by all of us. Yet in many ways, it has also been a banner year for people with lupus. We have seen a true renaissance in research with significant breakthroughs and major new treatment advances. After a decade with only one treatment for lupus approved in half a century, we recently saw the approval of […] READ MORE
April 28, 2021 In a new study led by Dr. Jason S. Knight and funded by the Lupus Research Alliance, researchers found a way to block inflammation by targeting a key protein, IRE1α, found in immune cells that are active in lupus, known as neutrophils. Dr. Knight’s team found that this protein could control some […] READ MORE
April 28, 2021 Xavier Goss is one of the most effective fundraisers for the Lupus Research Alliance ManyOne Can.Walk with Us to Cure Lupus program. Why? Because he’s friendly! Being ready to talk to everyone, caring, and eager to help others is his secret to success. Xavier first became involved with the LRA since 2005 […] READ MORE
April 20, 2021 At a public meeting in March led by the Institute for Clinical and Economic Review (ICER), an independent panel voted unanimously that both belimumab (Benlysta) and voclosporin (Lupkynis), newly approved to treat lupus nephritis, provide a health benefit over standard therapy alone. ICER’s policy recommendations for the use of these two medications […] READ MORE
April 14, 2021 Dr. Boris Reizis and his team, working with a group of clinical rheumatologists led by Dr. Jill Buyon, have made a connection between an enzyme that prevents people’s immune systems from reacting to their own DNA and lupus activity. In a paper just published in the Journal of Experimental Medicine they report […] READ MORE
April 8, 2021 In honor of National Siblings Day, we’re bringing you the story of TwoBeingHealthy — two sisters and strong social media voices – Kate (30) and Em (33) – who are so close they seem almost like twins. They went to the same college, live together in Seattle, hang out with the same […] READ MORE
March 31, 2021 As part of the LRA’s mission to accelerate development and availability of much-needed new diagnostics and treatments for lupus, the organization’s President and CEO, Mr. Kenneth M. Farber, submitted a letter to President Joseph Biden to express LRA’s strong support for Dr. Janet Woodcock to be nominated for Commissioner of the U.S. […] READ MORE
Dr. Eric Morand Publishes Results Funded by LRA’s Distinguished Innovator Award NEW YORK, NY. March 31, 2021. Results of critical work funded by the Lupus Research Alliance Distinguished Innovator Award to Dr. Eric Morand suggests a path toward making lupus treatment with glucocorticoids (steroids) effective at lower doses, lessening harmful side effects. In a study […] READ MORE
March 30, 2021 Equillium, Inc. announced positive topline data from the phase 1b EQUALISE study in patients with systemic lupus erythematosus (SLE). This study suggests that itolizumab, a monoclonal antibody selectively targeting the CD6-ALCAM pathway, was safe and well tolerated among people with SLE. [Source: Equillium, Inc. Press Release 3.30.21] The EQUALISE study is evaluating […] READ MORE
March 29, 2021 Patients with lupus are more likely to have metabolic syndrome and insulin resistance – both factors linked to heart disease – if they have lower vitamin D levels, a new study reveals. Researchers believe that boosting vitamin D levels may improve control of these cardiovascular risk factors, as well as improving long-term […] READ MORE
NEW YORK, March 25, 2021 — The Lupus Research Alliance proudly announces two exceptional recipients of the 2020 Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity: Jacques Banchereau, PhD and Ignacio Sanz, MD. Both projects funded by this grant are investigating different mechanisms altered in lupus patients that induce an autoimmune response. Their findings […] READ MORE
